Health · 1 views

Liver-directed gene therapy shows preclinical efficacy for severe inherited metabolic disorder

Genespire, in collaboration with researchers at the San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), announced the publicatio…

Source Medical Xpress AI Summary Updated 1h 30m ago

Story intelligence Beta

Freshness Fresh Updated 1h 30m ago

Confidence Limited Single-outlet story

Coverage Single outlet

Views 1 Community interest

Read time 1 min ~42 words

AI Summary

Genespire, in collaboration with researchers at the San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), announced the publication of preclinical data supporting the potential of its liver-directed immune-shielded lentiviral gene therapy approach to treat methylmalonic acidemia (MMA), a severe inherited metabolic disorder.

Read full article on Medicalxpress

AI summaries can be wrong sometimes—always verify important details using the source article.